Table 4 Reported availability of staging investigations in the 30 English cancer networks
From: Re-organisation of oesophago-gastric cancer care in England: progress and remaining challenges
Investigation | Â | Patients on whom the investigation is performed | |||
|---|---|---|---|---|---|
| Â | Tumour site | In all patients | In selected patients | None | Missing values |
CT scan | Oesophageal | 28 (93%) | 2 (7%) | Â | Â |
| Â | Junctional | 28 (93%) | 2 (7%) | Â | Â |
| Â | Gastric | 28 (93%) | 2 (7%) | Â | Â |
Endoscopic | Oesophageal | 17 (57%) | 13 (43%) | Â | Â |
Ultrasound (EUS) | Junctional | 16 (53%) | 14 (47%) | Â | Â |
| Â | Gastric | 3 (10%) | 22 (73%) | 5 (17%) | Â |
Staging | Oesophageal | 2 (7%) | 25 (86%) | 2 (7%) | 1 |
Laparoscopy | Junctional | 12 (41%) | 17 (59%) | Â | 1 |
| Â | Gastric | 19 (66%) | 10 (34%) | Â | 1 |
EUS Fine | Oesophageal | 3 (10%) | 20 (67%) | 7 (20%) | Â |
Needle | Junctional | 3 (10%) | 20 (67%) | 7 (20%) | Â |
Aspiration | Gastric | 2 (7%) | 17 (57%) | 11 (37%) | Â |
PET Scan | Oesophageal | 10 (33%) | 17 (57%) | 3 (10%) | Â |
| Â | Junctional | 8 (4%) | 19 (63%) | 3 (10%) | Â |
| Â | Gastric | 2 (7%) | 16 (53%) | 11 (37%) | Â |
PET-CT | Oesophageal | 7 (23%) | 21 (70%) | 2 (7%) | Â |
| Â | Junctional | 6 (20%) | 22 (73%) | 2 (7%) | Â |
| Â | Gastric | 1 (3%) | 19 (63%) | 10 (33%) | Â |